Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) 64% LOWER; announced top-line results from the Phase 3 clinical trial of its lead drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

UBS Remains Bullish as Morgan Stanley (MS) Provides Clarity on FICC Business Restructuring January 20, 2016 9:36 AM UBS Says Bank of America (BAC) Weakness is Due to Energy Exposure Concerns - Cuts PT to $18 January 20, 2016 9:06 AM FBR Capital Remains Bullish as Bank of America's (BAC) 4Q was Weighted by U.K. Tax Charges January 20, 2016 7:05 AM Mizuho Securities Remains Bullish on Tiffany & Co. (TIF) Despite Weak Holiday Sales - PT to $75 January 19, 2016 2:34 PM Morgan Stanley's Base Case on Shopify (SHOP) Suggests 71% Upside, Bull Case 207%January 19, 2016 11:13 AM